Bank Julius Baer & Co
LTRN icon

Bank Julius Baer & Co’s Lantern Pharma LTRN Stock Holding History

Bank Julius Baer & Co’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,500
Closed -$20K – 712
2021
Q4 		$20K Buy
2,500
+1,000
+67% +$9.13K ﹤0.01% 737
2021
Q3 		$17K Buy
1,500
+473
+46% +$6.12K ﹤0.01% 752
2021
Q2 		$15K Buy
1,027
+27
+3% +$417 ﹤0.01% 773
2021
Q1 		$18K Buy
+1,000
New +$17.5K ﹤0.01% 754

Other funds holding LTRN

SMH
Sanders Morris Harris Houston, Texas $172M AUM 22.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
CC
Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
RAM
Redmond Asset Management Henrico, Virginia $366M AUM 10.64% 1-Year Est. Return
WWM
Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bank Julius Baer & Co's LTRN Position: Q1 2022 in Review

Bank Julius Baer & Co sold out of Lantern Pharma (LTRN) in Q1 2022, closing a stake of 2,500 shares — an estimated $20K sold.

Bank Julius Baer & Co first reported a position in LTRN in Q1 2021 and held it in 4 quarters. The position peaked at $20K in Q4 2021. 25 funds tracked by Wall St. Rank hold LTRN as of Q1 2022.

  • Bank Julius Baer & Co reported no remaining Lantern Pharma position as of Q1 2022 after selling out during the quarter.
  • Bank Julius Baer & Co sold 2,500 Lantern Pharma shares in Q1 2022, an estimated $20K.
  • Bank Julius Baer & Co first reported a position in Lantern Pharma in Q1 2021 and held it in 4 quarters.
  • Bank Julius Baer & Co's Lantern Pharma position peaked at $20K in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Lantern Pharma as of Q1 2022.

Based on Bank Julius Baer & Co's 13F filing for Q1 2022, filed 9 May 2022.